Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.

Patel KR, Solomon IH, El-Mofty SK, Lewis JS Jr, Chernock RD.

Hum Pathol. 2013 Nov;44(11):2501-8. doi: 10.1016/j.humpath.2013.06.010. Epub 2013 Sep 10.

PMID:
24029710
2.

Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.

Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH.

Hum Pathol. 2013 Oct;44(10):1982-8. doi: 10.1016/j.humpath.2013.03.017. Epub 2013 Jun 14.

3.

Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.

Majewska H, Skálová A, Stodulski D, Klimková A, Steiner P, Stankiewicz C, Biernat W.

Virchows Arch. 2015 Mar;466(3):245-54. doi: 10.1007/s00428-014-1701-8. Epub 2014 Dec 12.

4.

A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?

Projetti F, Lacroix-Triki M, Serrano E, Vergez S, Barres BH, Meilleroux J, Delisle MB, Uro-Coste E.

J Oral Pathol Med. 2015 Apr;44(4):244-51. doi: 10.1111/jop.12226. Epub 2014 Jul 18.

PMID:
25040635
5.

Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.

Pinto A, Nosé V, Rojas C, Fan YS, Gomez-Fernandez C.

Mod Pathol. 2014 Jan;27(1):30-7. doi: 10.1038/modpathol.2013.84. Epub 2013 Jun 28. Erratum in: Mod Pathol. 2014 Jun;27(6):918.

6.

Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.

Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I.

Am J Surg Pathol. 2012 Jan;36(1):27-34. doi: 10.1097/PAS.0b013e318231542a.

PMID:
21989350
7.

Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.

Urano M, Nagao T, Miyabe S, Ishibashi K, Higuchi K, Kuroda M.

Hum Pathol. 2015 Jan;46(1):94-103. doi: 10.1016/j.humpath.2014.09.012. Epub 2014 Oct 7.

PMID:
25456394
8.

Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.

Stevens TM, Kovalovsky AO, Velosa C, Shi Q, Dai Q, Owen RP, Bell WC, Wei S, Althof PA, Sanmann JN, Sweeny L, Carroll WR, Siegal GP, Bullock MJ, Brandwein-Gensler M.

Mod Pathol. 2015 Aug;28(8):1084-100. doi: 10.1038/modpathol.2015.64. Epub 2015 Jun 19.

10.

Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.

Kawahara A, Taira T, Abe H, Takase Y, Kurita T, Sadashima E, Hattori S, Imamura I, Matsumoto S, Fujisaki H, Sueyoshi K, Akiba J, Kage M.

Cancer Cytopathol. 2015 Oct;123(10):603-11. doi: 10.1002/cncy.21594. Epub 2015 Aug 7.

PMID:
26252941
11.

Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas.

Bishop JA, Yonescu R, Batista D, Eisele DW, Westra WH.

Am J Surg Pathol. 2013 Jul;37(7):1053-7. doi: 10.1097/PAS.0b013e3182841554.

12.

Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.

Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M.

Am J Surg Pathol. 2010 May;34(5):599-608. doi: 10.1097/PAS.0b013e3181d9efcc.

PMID:
20410810
13.

Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification.

Mariano FV, dos Santos HT, Azañero WD, da Cunha IW, Coutinho-Camilo CM, de Almeida OP, Kowalski LP, Altemani A.

Histopathology. 2013 Oct;63(4):558-67. doi: 10.1111/his.12192. Epub 2013 Aug 12.

PMID:
23931576
14.

Mammary analogue secretory carcinoma mimicking salivary adenoma.

Williams L, Chiosea SI.

Head Neck Pathol. 2013 Dec;7(4):316-9. doi: 10.1007/s12105-013-0443-2. Epub 2013 Apr 26.

16.

Fine-needle aspiration cytology of mammary analog secretory carcinoma masquerading as low-grade mucoepidermoid carcinoma: case report with a review of the literature.

Bajaj J, Gimenez C, Slim F, Aziz M, Das K.

Acta Cytol. 2014;58(5):501-10. doi: 10.1159/000368070. Epub 2014 Oct 23.

PMID:
25342157
17.

Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.

Ito Y, Ishibashi K, Masaki A, Fujii K, Fujiyoshi Y, Hattori H, Kawakita D, Matsumoto M, Miyabe S, Shimozato K, Nagao T, Inagaki H.

Am J Surg Pathol. 2015 May;39(5):602-10. doi: 10.1097/PAS.0000000000000392.

PMID:
25651470
18.

The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases.

Griffith CC, Stelow EB, Saqi A, Khalbuss WE, Schneider F, Chiosea SI, Seethala RR.

Cancer Cytopathol. 2013 May;121(5):234-41. doi: 10.1002/cncy.21249. Epub 2012 Dec 5.

19.

Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands.

Chiosea SI, Griffith C, Assaad A, Seethala RR.

Histopathology. 2012 Sep;61(3):387-94. doi: 10.1111/j.1365-2559.2012.04232.x. Epub 2012 Feb 28.

PMID:
22372712
20.

Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.

Prasad ML, Barbacioru CC, Rawal YB, Husein O, Wen P.

Mod Pathol. 2008 Feb;21(2):105-14. Epub 2007 Dec 14.

Items per page

Supplemental Content

Write to the Help Desk